Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients

Author： Albaaj Fouad Hutchison Alastair J

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.2, 2005-02, pp. : 319-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure

Current Medicinal Chemistry, Vol. 25, Iss. 1, 2018-01 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperphosphataemia in Renal Failure: Causes, Consequences and Current Management

By Albaaj F. Hutchison A.J.

Drugs, Vol. 63, Iss. 6, 2003-01 ,pp. : 577-596

Adis International

Access to resources Recommend Favorite

Management of Hyperphosphataemia in Dialysis Patients: Role of Phosphate Binders in the Elderly

By Víctor Lorenzo Sellares Armando Torres Ramírez

Drugs & Aging, Vol. 21, Iss. 3, 2004-01 ,pp. : 153-165

Adis International

Access to resources Recommend Favorite

Sodium phosphate: Hyperphosphataemia, hypocalcaemia, seizures in a patient with renal failure: case report

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

By Curran Monique P. Robinson Dean M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2329-2349

Adis International

Access to resources Recommend Favorite